Development and some characteristics of a P388 leukemia strain resistant to 1, 2 : 5, 6-dianhydrogalactitol

This publication has 21 references indexed in Scilit:

• Mutagenicity of dibromodulcitol (DBD), an alkylating anticancer drug) and its mono- and bifunctional conversion products studied by the Salmonella/microsome assay
  Carcinogenesis: Integrative Cancer Research, 1982
• Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine
  Biochemical Journal, 1980
• A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cells
  Cancer Letters, 1980
• Absence of cross-resistance to alkylating agents in cyclophosphamide-resistant L1210 leukemia
  Published by Elsevier ,1978
• Melphalan‐induced chromosome damage in sensitive and resistant human melanoma cell lines
  International Journal of Cancer, 1978
• A Dose-Response Study of Resistance of Leukemia L1210 to Cyclophosphamide2
  JNCI Journal of the National Cancer Institute, 1973
• The establishment of cloned cell lines from Yoshida sarcomas having differential sensitivities to methylene dimethane sulphonate in vivo and their cross-sensitivity to X-rays, UV and other alkylating agents
  Chemico-Biological Interactions, 1972
• The role of the carrying molecule in the cross-resistance against sugar alcohol derivatives
  European Journal of Cancer (1965), 1969
• Studies on cross-resistance to degranol- and dibromodulcitol-resistant yoshida tumours
  International Journal of Cancer, 1968
• Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
  British Journal of Cancer, 1967